Researchers at UT Southwestern Medical Center in Dallas have developed new methods for analyzing the large amount of data generated by whole-genome sequencing used to identify patients at risk for hereditary cancers.

Results of the study, the first to leverage whole-genome sequencing to evaluate a series of 258 cancer patients’ genomes to improve the ability to diagnose cancer-predisposing mutations, are posted online in the journal EBioMedicine.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access